Use of teriparatide off-label: our experience and review of literature.

Q3 Medicine

Clinical Cases in Mineral and Bone Metabolism Pub Date : 2017-01-01 Epub Date: 2017-05-30 DOI:10.11138/ccmbm/2017.14.1.028

Emanuele Ciurlia, Paolo Tranquilli Leali, Carlo Doria

引用次数: 11

Abstract

The aim of this paper is to report our experience and to present a review of literature about the use of teriparatide off-label in the therapy of non-unions. Teriparatide is used exclusively in treatment of osteoporosis and to prevent bone fracture because it has a positive effect on bone strength and architecture. The use of teriparatide in non-unions is described as effective in numerous case report.

Abstract Image

查看原文本刊更多论文

特立帕肽说明书外用药:我们的经验和文献回顾。

本文的目的是报告我们的经验，并提出文献综述使用特立帕肽标签外治疗骨不连。特立帕肽专门用于治疗骨质疏松症和预防骨折，因为它对骨骼强度和结构有积极作用。在许多病例报告中，使用特立帕肽治疗骨不连是有效的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Cases in Mineral and Bone Metabolism ENDOCRINOLOGY & METABOLISM-

CiteScore

2.60

自引率

0.00%

发文量

期刊介绍： The Journal encourages the submission of case reports and clinical vignettes that provide new and exciting insights into the pathophysiology and characteristics of disorders related to skeletal function and mineral metabolism and/or highlight pratical diagnostic and /or therapeutic considerations.